(OHI) Omega Healthcare Investors - Overview

Sector: Real Estate | Industry: REIT - Healthcare Facilities | Exchange: NYSE (USA) | Market Cap: 13.670m USD | Total Return: 32.6% in 12m

Healthcare Facilities, Real Estate, Investments
Total Rating 51
Safety 52
Buy Signal -0.19
REIT - Healthcare Facilities -13.8
Health Care REITs -14.2
Market Cap: 13,670m
Avg Trading Vol: 81.6M USD
ATR: 2.12%
Peers RS (IBD): 63.3
Risk 5d forecast
Volatility21.4%
Rel. Tail Risk-3.10%
Reward TTM
Sharpe Ratio1.08
Alpha22.95
Character TTM
Beta-0.065
Beta Downside-0.239
Drawdowns 3y
Max DD15.47%
CAGR/Max DD1.79
EPS (Earnings per Share) EPS (Earnings per Share) of OHI over the last years for every Quarter: "2021-03": 0.69, "2021-06": 0.36, "2021-09": 0.58, "2021-12": 0.14, "2022-03": 0.79, "2022-06": 0.38, "2022-09": 0.43, "2022-12": 0.19, "2023-03": 0.15, "2023-06": 0.25, "2023-09": 0.37, "2023-12": 0.22, "2024-03": 0.27, "2024-06": 0.45, "2024-09": 0.47, "2024-12": 0.4, "2025-03": 0.41, "2025-06": 0.5, "2025-09": 0.5887, "2025-12": 0.55, "2026-03": 0,
EPS CAGR: -46.91%
EPS Trend: 23.0%
Last SUE: -4.00
Qual. Beats: 0
Revenue Revenue of OHI over the last years for every Quarter: 2021-03: 273.768, 2021-06: 257.42, 2021-09: 281.672, 2021-12: 249.949, 2022-03: 249.315, 2022-06: 244.649, 2022-09: 239.43, 2022-12: 144.85, 2023-03: 218.202, 2023-06: 250.187, 2023-09: 242.032, 2023-12: 239.319, 2024-03: 243.299, 2024-06: 252.745, 2024-09: 276.028, 2024-12: 279.318, 2025-03: 276.785, 2025-06: 282.506, 2025-09: 311.591, 2025-12: 321.817, 2026-03: null,
Rev. CAGR: 7.04%
Rev. Trend: 64.9%
Last SUE: 3.38
Qual. Beats: 1
Warnings

No concerns identified

Tailwinds

No distinct edge detected

Description: OHI Omega Healthcare Investors

Omega Healthcare Investors Inc. (OHI) operates as a Real Estate Investment Trust (REIT) specializing in the long-term healthcare sector. The company provides financing and capital for skilled nursing and assisted living facilities in the US and UK.

As of a recent reporting period, OHIs portfolio comprised over 1,000 operating facilities across 42 US states, the District of Columbia, and the UK/Jersey, managed by numerous operators. Healthcare REITs typically lease properties to healthcare providers under long-term agreements.

OHI focuses on identifying long-term investments in quality healthcare properties with strong operators, aiming for favorable risk/reward profiles. The long-term healthcare sector faces evolving regulatory and demographic challenges. For more detailed financial analysis, ValueRay offers comprehensive data.

Headlines to Watch Out For
  • Skilled nursing facility occupancy rates impact rental income
  • Interest rate fluctuations affect borrowing costs and property valuations
  • Healthcare regulatory changes influence operator profitability
  • Operator financial health directly impacts rent collection
  • Demographic shifts drive demand for long-term care facilities
Piotroski VR‑10 (Strict) 5.0
Net Income: 590.1m TTM > 0 and > 6% of Revenue
FCF/TA: 0.09 > 0.02 and ΔFCF/TA 1.36 > 1.0
NWC/Revenue: 122.7% < 20% (prev 219.6%; Δ -96.87% < -1%)
CFO/TA 0.09 > 3% & CFO 879.7m > Net Income 590.1m
Net Debt (4.23b) to EBITDA (1.17b): 3.62 < 3
Current Ratio: 3.46 > 1.5 & < 3
Outstanding Shares: last quarter (313.2m) vs 12m ago 8.97% < -2%
Gross Margin: 84.91% > 18% (prev 0.99%; Δ 8.39k% > 0.5%)
Asset Turnover: 11.96% > 50% (prev 10.62%; Δ 1.34% > 0%)
Interest Coverage Ratio: 3.92 > 6 (EBITDA TTM 1.17b / Interest Expense TTM 215.1m)
Altman Z'' -0.45
A: 0.15 (Total Current Assets 2.06b - Total Current Liabilities 594.5m) / Total Assets 10.05b
B: -0.36 (Retained Earnings -3.62b / Total Assets 10.05b)
C: 0.08 (EBIT TTM 842.4m / Avg Total Assets 9.97b)
D: -0.76 (Book Value of Equity -3.51b / Total Liabilities 4.61b)
Altman-Z'' Score: -0.45 = B
Beneish M -2.70
DSRI: 0.87 (Receivables 2.00b/2.03b, Revenue 1.19b/1.05b)
GMI: 1.16 (GM 84.91% / 98.62%)
AQI: 1.38 (AQ_t 0.13 / AQ_t-1 0.09)
SGI: 1.13 (Revenue 1.19b / 1.05b)
TATA: -0.03 (NI 590.1m - CFO 879.7m) / TA 10.05b)
Beneish M-Score: -2.70 (Cap -4..+1) = A
What is the price of OHI shares? As of April 06, 2026, the stock is trading at USD 45.00 with a total of 1,513,300 shares traded.
Over the past week, the price has changed by +2.04%, over one month by -4.40%, over three months by +4.43% and over the past year by +32.59%.
Is OHI a buy, sell or hold? Omega Healthcare Investors has received a consensus analysts rating of 3.69. Therefor, it is recommend to hold OHI.
  • StrongBuy: 4
  • Buy: 3
  • Hold: 9
  • Sell: 0
  • StrongSell: 0
What are the forecasts/targets for the OHI price?
Wallstreet Target Price 49.6 10.3%
Analysts Target Price 49.6 10.3%
OHI Fundamental Data Overview as of 04 April 2026
P/E Trailing = 23.1959
P/E Forward = 10.1317
P/S = 11.4865
P/B = 2.5288
P/EG = 11.994
Revenue TTM = 1.19b USD
EBIT TTM = 842.4m USD
EBITDA TTM = 1.17b USD
Long Term Debt = 4.26b USD (from longTermDebt, last quarter)
Short Term Debt = 242.0m USD (from shortTermDebt, last quarter)
Debt = 4.26b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 4.23b USD (from netDebt column, last quarter)
Enterprise Value = 17.90b USD (13.67b + Debt 4.26b - CCE 27.0m)
Interest Coverage Ratio = 3.92 (Ebit TTM 842.4m / Interest Expense TTM 215.1m)
EV/FCF = 20.82x (Enterprise Value 17.90b / FCF TTM 859.8m)
FCF Yield = 4.80% (FCF TTM 859.8m / Enterprise Value 17.90b)
FCF Margin = 72.09% (FCF TTM 859.8m / Revenue TTM 1.19b)
Net Margin = 49.47% (Net Income TTM 590.1m / Revenue TTM 1.19b)
Gross Margin = 84.91% ((Revenue TTM 1.19b - Cost of Revenue TTM 179.9m) / Revenue TTM)
Gross Margin QoQ = 47.22% (prev none%)
Tobins Q-Ratio = 1.78 (Enterprise Value 17.90b / Total Assets 10.05b)
Interest Expense / Debt = 1.22% (Interest Expense 51.8m / Debt 4.26b)
Taxrate = 1.22% (2.13m / 174.1m)
NOPAT = 832.1m (EBIT 842.4m * (1 - 1.22%))
Current Ratio = 3.46 (Total Current Assets 2.06b / Total Current Liabilities 594.5m)
Debt / Equity = 0.82 (Debt 4.26b / totalStockholderEquity, last quarter 5.18b)
Debt / EBITDA = 3.62 (Net Debt 4.23b / EBITDA 1.17b)
Debt / FCF = 4.92 (Net Debt 4.23b / FCF TTM 859.8m)
Total Stockholder Equity = 4.99b (last 4 quarters mean from totalStockholderEquity)
RoA = 5.92% (Net Income 590.1m / Total Assets 10.05b)
RoE = 11.83% (Net Income TTM 590.1m / Total Stockholder Equity 4.99b)
RoCE = 9.11% (EBIT 842.4m / Capital Employed (Equity 4.99b + L.T.Debt 4.26b))
RoIC = 8.61% (NOPAT 832.1m / Invested Capital 9.66b)
WACC = 4.67% (E(13.67b)/V(17.93b) * Re(5.75%) + D(4.26b)/V(17.93b) * Rd(1.22%) * (1-Tc(0.01)))
Discount Rate = 5.75% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.92%
Shares Correlation 3-Years: 100.0 | Cagr: 10.49%
[DCF] Terminal Value 86.92% ; FCFF base≈801.0m ; Y1≈850.7m ; Y5≈1.02b
[DCF] Fair Price = 87.34 (EV 30.05b - Net Debt 4.23b = Equity 25.82b / Shares 295.6m; r=6.0% [WACC]; 5y FCF grow 6.85% → 3.0% )
EPS Correlation: 23.05 | EPS CAGR: -46.91% | SUE: -4.0 | # QB: 0
Revenue Correlation: 64.92 | Revenue CAGR: 7.04% | SUE: 3.38 | # QB: 1
EPS next Quarter (2026-06-30): EPS=0.54 | Chg7d=+0.068 | Chg30d=+0.068 | Revisions Net=+1 | Analysts=1
EPS current Year (2026-12-31): EPS=2.04 | Chg7d=-0.007 | Chg30d=-0.007 | Revisions Net=+1 | Growth EPS=+0.3% | Growth Revenue=+13.5%
EPS next Year (2027-12-31): EPS=2.15 | Chg7d=+0.045 | Chg30d=+0.045 | Revisions Net=+1 | Growth EPS=+5.3% | Growth Revenue=+5.8%
External Resources
Dataroma Stockcircle